by 489.ai
専門領域の医師向けの論文紹介podcastです。 放射線科画像診断学に関連する新着論文を厳選し、毎日10本程度紹介します。 GPT4-APIを利用して日本語要約し、AI音声で読み上げます。 メール配信がメインのサービスです。配信登録は医師限定ですが、興味があれば下記をごらんください。 https://489.ai/
Language
🇯🇵
Publishing Since
9/13/2023
Email Addresses
1 available
Phone Numbers
0 available
November 21, 2024
Dr. Takeshi Nakamura introduces the latest radiology AI summaries, providing medical professionals with expert insights and cutting-edge research to enhance their diagnostic expertise.
November 18, 2024
11月19日の放射線科画像診断に関連する新着論文紹介です。専門医取得済みの医師を想定して作成しています。 メール配信がメインのサービスです。メール配信登録は医師限定ですが、興味があれば下記をごらんください。 <a href="https://489.ai/">https://489.ai/</a>
November 17, 2024
11月18日の放射線科画像診断に関連する新着論文紹介です。専門医取得済みの医師を想定して作成しています。 メール配信がメインのサービスです。メール配信登録は医師限定ですが、興味があれば下記をごらんください。 <a href="https://489.ai/">https://489.ai/</a>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.